Vimarsana
Biggest News Aggregation in the World

Viewpoint Molecular News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Viewpoint Molecular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Viewpoint Molecular Today - Breaking & Trending Today

Neuroendocrine Tumors Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Key Companies to Watch Out - Merck, BioXcel, Boehringer Ingelheim, RayzeBio, Vyriad, Roche, Monte Rosa, Amgen - Vimarsana News

Neuroendocrine Tumors Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Key Companies to Watch Out - Merck, BioXcel, Boehringer Ingelheim, RayzeBio, Vyriad, Roche, Monte Rosa, Amgen

/PRNewswire/ -- DelveInsight's Neuroendocrine Tumors Market Insights report includes a comprehensive understanding of current treatment practices,...

Perspective Therapeutics Announces Changes to the Board of - Vimarsana News

Perspective Therapeutics Announces Changes to the Board of

Heidi Henson was appointed to the Board of Directors and named Audit Committee Chair taking over from Rob Williamson, III, who will continue to serve as a...

Perspective Therapeutics Announces Changes to the Board of Directors - Vimarsana News

Perspective Therapeutics Announces Changes to the Board of Directors

Heidi Henson was appointed to the Board of Directors and named Audit Committee Chair taking over from Rob Williamson, III, who will continue to serve as a member of the CommitteeMichael McCormick... | May 15, 2023

Perspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022 - Vimarsana News

Perspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022

RICHLAND, Wash. and CORALVILLE, Iowa, Feb. 16, 2023 -- Perspective Therapeutics, Inc. , a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents... | February 16, 2023

AMENDED: Isoray Announces Adjournment of Annual Meeting of - Vimarsana News

AMENDED: Isoray Announces Adjournment of Annual Meeting of

RICHLAND, Wash., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy...